The incidence of hepatocellular carcinoma (HCC) is still rising, making it one of the most common malignancies worldwide [ 1 x [1] Llovet, J.M., Burroughs, A., and Bruix, J. Hepatocellular carcinoma. Lancet. 2003; 362: 1907–1917 Abstract | Full Text | Full Text PDF | PubMed | Scopus (3242) | Google Scholar See all References ] [1] . Up to now, surgical resection (RES) has been considered the first choice treatment [ 2 x [2] Lee, C.S., Sheu, J.C., Wang, M., and Hsu, H.C. Long-term outcome after surgery for asymptomatic small hepatocellular carcinoma. Br J Surg. 1996; 83: 330–333 Crossref | PubMed | Scopus (60) | Google Scholar See all References , 3 x [3] Lai, E.C., Fan, S.T., Lo, C.M., Chu, K.M., Lu, C.L., and Wong, J. Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Ann Surg. 1995; 221: 291–298 Crossref | PubMed | Scopus (372) | Google Scholar See all References , 4 x [4] Bruix, J. and Sherman, M. Management of hepatocellular carcinoma. Hepatology. 2005; 42: 1208–1236 Crossref | PubMed | Scopus (4214) | Google Scholar See all References ]. Orthotopic liver transplantation (OLT) guarantees the best long-term survival and disease-free survival in selected patients because it removes the tumor as well as the cirrhotic liver [ 5 x [5] Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., and Bozzetti, F. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334: 693–699 Crossref | PubMed | Scopus (4393) | Google Scholar See all References , 6 x [6] Bismuth, H., Majino, P.E., and Adam, R. Liver transplantation for the treatment of hepatocellular carcinoma. Semin Liver Dis. 1999; 19: 311–322 Crossref | PubMed | Google Scholar See all References , 7 x [7] Llovet, J.M., Fuster, J., and Bruix, J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999; 30: 1434–1440 Crossref | PubMed | Scopus (1286) | Google Scholar See all References ]. Nevertheless, the shortage of organs makes it possible to treat only a small proportion of patients by OLT. Improvements in imaging and technology have promoted the development of percutaneous techniques such as transcatheter arterial embolization (TACE), percutaneous ethanol injection (PEI), percutaneous acetic injection (PAI), cryo-ablation, and radiofrequency ablation (RFA). Some of these techniques are currently less used (PAI, cryo-ablation) while TACE is mainly employed for advanced HCC [ 8 x [8] Bruix, J., Sala, M., and Llovet, J.M. Chemoembolization for hepatocellular carcinoma. Gastroenterology. 2004; 127: S179–S188 Abstract | Full Text | Full Text PDF | PubMed | Scopus (420) | Google Scholar See all References ] [8] . RFA appears to be one of the most efficacious percutaneous techniques for HCC ablation, thanks to its predictable area of induced necrosis and percentage of induced necrotic cells, checked at the histological examination [ 9 x [9] Livraghi, T., Goldberg, S.N., Lazzaroni, S., Meloni, F., Solbiati, L., and Gazelle, G.S. Small hepatocellular carcinoma: treatment with radio-frequency thermal ablation versus ethanol injection. Radiology. 1999; 210: 655–661 Crossref | PubMed | Scopus (1129) | Google Scholar See all References , 10 x [10] Lencioni, R.A., Allgaier, H.P., Cioni, D., Olschewski, M., Deibert, P., and Crocetti, L. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003; 228: 235–240 Crossref | PubMed | Scopus (781) | Google Scholar See all References , 11 x [11] Lin, S.M., Lin, C.J., Lin, C.C., Hsu, C.W., and Chen, Y.C. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4cm. Gastroenterology. 2004; 127: 1714–1723 Abstract | Full Text | Full Text PDF | PubMed | Scopus (484) | Google Scholar See all References , 12 x [12] Shiina, S., Teratani, T., Obi, S., Sato, S., Tateishi, R., and Fujishima, T. A randomized controlled trial of radiofrequency ablation with ethanol injection for hepatocellular carcinoma. Gastroenterology. 2005; 129: 122–130 Abstract | Full Text | Full Text PDF | PubMed | Scopus (627) | Google Scholar See all References , 13 x [13] Lu, D.S., Yu, N.C., Raman, S.S., Limanond, P., Lassman, C., and Murray, K. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology. 2005; 234: 954–960 Crossref | PubMed | Scopus (261) | Google Scholar See all References ]. In the recent past RFA was mainly reserved for patients with compromised hepatic function, who were not eligible for surgery. It was also reserved for patients with smaller tumors, since percutaneous ablative procedures were considered less efficacious for bigger HCCs [ 14 x [14] Wakai, T., Shirai, Y., Suda, T., Yokoyama, N., Sakata, J., and Cruz, P. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma ≤4 cm. World J Gastroenterol. 2006; 12: 546–552 PubMed | Google Scholar See all References ] [14] . However, clinical trials have recently demonstrated that RFA shows a similar long-term outcome to resection in the treatment of small HCCs. From the literature it is not clear how comparable the two techniques are for larger HCCs (>3 cm). The aim of this study was to compare the outcome of RFA and RES in patients at first diagnosis of a single HCC, ranging in size from 3 to 5 cm, and with similar liver function (Child Pugh class A or B).